• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Arthocare sells off spine product lines for $5.5 million | Acquisitions roundup

Arthocare sells off spine product lines for $5.5 million | Acquisitions roundup

July 5, 2011 By MassDevice staff

Mergers and Acquisitions

ArthroCare Corp. (NSDQ:ARTC) sold its Parallax and Contour product lines to NeuroTherm for $5.5 million.

The two lines of spine products were previously reported as discontinued operations.

Wilmington, Mass.-based NeuroTherm manufactures products used in pain management, including the first multi-lesion radiofrequency generator on the market, according to a company release.

"ArthroCare’s Parallax portfolio is a natural fit with NeuroTherm’s existing competencies in interventional pain management, allowing us to leverage our clinical expertise and strong sales channels," said NeuroTherm CEO Larry Hicks in a release. "This is an exciting opportunity that will enable us to expand our customer base into new markets while offering our existing customers more treatment options for their patients."

Arthrocare expects an after-tax gain of $1.2 million from the sale in its second quarter, according to the SEC filing.

Here’s a roundup of companies announcing mergers, acquisitions and divestitures.

  • Mindray to buy urine analysis company
    Mindray Medical International Ltd. (NYSE:MR) agreed to acquire a controlling stake in Suzhou Hyssen Electronics Co. Ltd, a China-based maker of automated urine sediment analyzers. The details of the agreement were not disclosed, as the transaction is non-material to Mindray’s financial statements, according to a company release. Oppenheimer analysts reiterated their "outperform" rating on the company’s stock today, Benzinga reported.
    Read more
  • Fresenius completes dialysis service acquisition
    Fresenius Medical Care AG (NYSE:FMS) completed its acquisition of Euromedic’s International Dialysis Centers, effective June 30, 2011. Fresenius first announced the acquisition in January of this year. The deal will add about $180 million in annual revenue and will be accretive in the first year, the company said at the time. The details of the transaction were not made public.
    Read more

Filed Under: Mergers & Acquisitions, News Well, Pain Management Tagged With: ArthroCare Corp., Fresenius, Mindray Medical International Ltd., NeuroTherm Inc.

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy